DDD pacing mode survival in patients with a dual-chamber pacemaker

Department of Medicine, Montefiore Medical Center, Bronx, New York 10467.

Dual-chamber (DDD) pacing mode survival was assessed by reviewing 486 consecutive initial transvenous DDD pacemaker implantations between December 1981 and December 1988 inclusive, with a mean follow-up time of 33 months. The patients' mean age was 71.4 years and 55% were male; 38% had dominant sinoatrial and 62% had dominant atrioventricular (AV) node disease. Nineteen patients (4%) underwent secondary operative intervention for lead dislodgement (n = 11), lead or pulse generator malfunction (n = 6) or infection (n = 2). During follow-up, 87 patients (18%) had their device permanently reprogrammed out of the DDD mode and 10 others (2%) required temporary reprogramming out of this mode; 12 patients who required device reprogramming were managed in other dual-chamber or atrial pacing modes. Reasons for reprogramming included atrial fibrillation (n = 48; 10%); loss of atrial sensing (n = 26; 5%); recurrent "endless loop" tachycardia (n = 5; 1%); lead dislodgement without repositioning (n = 4; 1%); pulse generator malfunction (n = 1; 1%) and other (n = 5; 1%). The occurrence of atrial fibrillation was associated with dominant sinoatrial disease and a prior history of atrial fibrillation; 19% of atrial sensing loss was attributable to early or faulty pacemaker technology. The DDD mode survival rate at 1, 2, 3, 4 and 5 years was, respectively, 90%, 88%, 84%, 79% and 78%.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				U.K.H Wiegand, J Potratz, F Bode, R Schreiber, H Bonnemeier, W Peters, and H.A Katus Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block? Eur. Heart J., January 2, 2001; 22(2): 174 - 180. [Abstract] [PDF]

				E. Valsangiacomo, L. Molinari, M. Rahn-Schonbeck, and U. Bauersfeld DDD pacing mode survival in children with a dual-chamber pacemaker Ann. Thorac. Surg., December 1, 2000; 70(6): 1931 - 1934. [Abstract] [Full Text] [PDF]

				U K H Wiegand, F Bode, R Schneider, A Brandes, H Haase, H A Katus, and J Potratz Development of sinus node disease in patients with AV block: implications for single lead VDD pacing Heart, June 1, 1999; 81(6): 580 - 585. [Abstract] [Full Text]

				J. M. McComb and G. M. Gribbin Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: Determinants and treatment Europace, January 1, 1999; 1(1): 30 - 34. [Abstract] [PDF]

				J.C. Nielsen, A.K. Pedersen, P.T. Mortensen, and H.R. Andersen Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome Europace, January 1, 1999; 1(2): 113 - 120. [Abstract] [PDF]

				J. Neuzner, J. Sperzel, H. F. Pitschner, T. Schwarz, W. Ehrlich, B. Schulte, and W. Haberbosch Bipolar atrial sensing thresholds in sinus rhythm and atrial tachyarrhythmias: A comparative analysis in patients with DDDR pacemakers Europace, January 1, 1999; 1(2): 135 - 139. [Abstract] [PDF]

				G M Gribbin, J P Bourke, and J M McComb Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias Heart, June 1, 1998; 79(6): 548 - 553. [Abstract] [Full Text]